Advertisement

Topics

Prothena Corporation plc: Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update

16:16 EDT 8 Aug 2017 | FinanzNachrichten

-- Net cash used in operating and investing activities was $36.3 million in the second quarter and $76.5 million for the first six months of 2017; quarter-end cash and restricted cash position of $...

Original Article: Prothena Corporation plc: Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update

NEXT ARTICLE

More From BioPortfolio on "Prothena Corporation plc: Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update"

Quick Search
Advertisement